Panattoni, Laura; Brown, Paul M.; Te Ao, Braden; … - In: PharmacoEconomics 30 (2012) 11, pp. 1067-1084
Background:Background: A recent clinical trial has demonstrated that patients with acute coronary syndromes (ACS) and the reduced function allele CYP2C19*2 (*2 allele), who are treated with thienopyridines, have an increased risk of adverse cardiac events with clopidogrel, but not with...